Galecto Biotech

Galecto Biotech

Galecto Biotech

our site
Founded
2011
Raised
$91.9M
Follow us
Alexa global traffic share
Acquired by
Bristol-Myers Squibb
04 Nov 2014
$444,000,000
Latest funding
€79,000,000
Venture capital (Series C) - 2018
Seventure Partners Sunstone Capital OrbiMed +7
Undisclosed amount
Venture capital - 2013
€79,000,000 Venture capital (Series C)
FinSMEs

Galecto Biotech Raises €79M in Series C Financing

Health Funding